OBJECTIVE
To obtain short peptides that bind specifically to ovarian carcinoma cell line HO8910 by whole-cell subtraction biopanning as an ideal vector for targeted drug delivery in ovarian cancer therapy.
METHODS
With the HO8910 ovarian carcinoma cells as the target cells and human normal ovarian epithelial cells as the adherent cells, 4 rounds of… (More)